Weiqing Huang Selected Research

Weiqing Huang Research Topics

Disease

13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 02/2002
7	Nephritis 08/2011 - 06/2002
6	Inflammation (Inflammations) 03/2022 - 07/2003
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2002
4	Proteinuria 11/2012 - 02/2002
3	Myocardial Infarction 01/2017 - 09/2004
2	Wounds and Injuries (Trauma) 03/2024 - 11/2021
2	Infections 10/2023 - 03/2016
2	Neoplasms (Cancer) 05/2016 - 03/2013
2	Lupus Nephritis 10/2012 - 08/2011
2	Thrombocytopenia (Thrombopenia) 04/2009 - 09/2004
2	Thrombosis (Thrombus) 09/2008 - 09/2004
1	COVID-19 12/2024
1	Body Weight (Weight, Body) 03/2024
1	Hemorrhage 03/2024
1	Pain (Aches) 03/2024
1	Postoperative Pain 03/2024
1	Starvation 01/2023
1	Allergic Rhinitis 03/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Keloid 11/2020
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hemorrhagic Shock 01/2019
1	Adenocarcinoma 05/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2013
1	Carcinogenesis 03/2013
1	Acute Lung Injury 10/2012
1	Glomerulonephritis 02/2008
1	Facial Paralysis (Facial Palsy) 05/2006
1	Paralysis (Palsy) 05/2006
1	Disease Progression 09/2004
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2004

Drug/Important Bio-Agent (IBA)

8	AutoantibodiesIBA 01/2022 - 09/2004
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2010
3	Immunoglobulin G (IgG)IBA 11/2012 - 01/2011
3	Antigen-Antibody Complex (Immune Complex)IBA 10/2012 - 07/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2011 - 07/2003
3	LigandsIBA 09/2004 - 02/2002
2	Long Noncoding RNAIBA 03/2022 - 11/2020
2	belimumabIBA 01/2018 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 07/2003
2	Cardiolipins (Cardiolipin)IBA 11/2012 - 09/2004
2	CytokinesIBA 10/2012 - 02/2008
2	InterferonsIBA 10/2012 - 01/2011
2	Abatacept (Orencia)FDA Link 08/2011 - 09/2004
2	TACI receptor-IgG Fc fragment fusion proteinIBA 05/2010 - 09/2004
2	ChemokinesIBA 02/2008 - 07/2003
2	AntibodiesIBA 03/2006 - 09/2004
1	VaccinesIBA 12/2024
1	Inosine Monophosphate (IMP)IBA 03/2024
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Complementary DNA (cDNA)IBA 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 11/2020
1	Tyrosine Kinase InhibitorsIBA 08/2020
1	HLA-D AntigensIBA 01/2020
1	Sirtuin 1IBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	anti-dsDNA autoantibodyIBA 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2016
1	Indicators and Reagents (Reagents)IBA 05/2016
1	Pregnane X ReceptorIBA 05/2016
1	Complement System Proteins (Complement)IBA 03/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2012
1	Epidermal Growth Factor (EGF)IBA 10/2012
1	EndotoxinsIBA 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012
1	Therapeutic UsesIBA 10/2012
1	AntigensIBA 12/2011
1	Interferon Type IIBA 04/2009
1	Toll-Like Receptor 7IBA 04/2009
1	Inflammation MediatorsIBA 09/2008
1	CalciumIBA 09/2004
1	B-Cell Activating FactorIBA 09/2004
1	CD40 Ligand (CD40L)IBA 02/2003
1	Monoclonal AntibodiesIBA 06/2002

Therapy/Procedure

7	Therapeutics 08/2011 - 02/2002
2	Transplantation 11/2021 - 05/2006
1	Anesthesia 03/2024
1	Minimally Invasive Surgical Procedures 03/2024
1	Length of Stay 01/2017
1	Drug Therapy (Chemotherapy) 05/2016
1	Remission Induction 02/2008